← The Wire
ALDXNasdaq
Aldeyra Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1341235
Developing and commercializing medicines for immune-mediated and metabolic diseases
red 8-K · 90d
$106M
Market cap
$2.05
Last close
+12.0%
1D
0.0%
5D
1.9M
Volume
Price · last 39 sessions+26.5%
May 4L $1.54 · H $2.05Jun 29
294
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 10, 202610-Q10-QMay 7, 20268-KReg FD DisclosureMay 1, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-KExecutive ChangeApr 20, 20268-KCompany UpdateApr 1, 20268-KReg FD Disclosure · Company UpdateMar 17, 202610-K10-KFeb 27, 20268-KExecutive ChangeDec 31, 20258-KReg FD Disclosure · Company UpdateDec 16, 20258-KReg FD Disclosure · Company UpdateNov 13, 202510-Q10-QNov 5, 20258-KCompany UpdateOct 28, 20258-KCompany UpdateAug 19, 202510-Q10-QAug 7, 20258-KCompany UpdateJul 17, 20258-KReg FD Disclosure · Company UpdateJun 26, 20258-KCompany UpdateJun 17, 20258-KShareholder VoteJun 11, 202510-Q10-QMay 14, 20258-KReg FD Disclosure · Company UpdateMay 6, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KExecutive ChangeApr 17, 20258-KReg FD Disclosure · Company UpdateApr 3, 202510-K/A10-K/AMar 28, 202510-K10-KFeb 28, 20258-KMaterial Agreement · Company UpdateNov 18, 202410-Q10-QNov 7, 20248-KCompany UpdateOct 3, 20248-KMaterial Agreement · New Debt / ObligationOct 2, 20248-KExecutive ChangeSep 3, 20248-KReg FD Disclosure · Company UpdateAug 8, 2024424B5424B5Aug 1, 20248-KMaterial AgreementAug 1, 202410-Q10-QAug 1, 20248-KCompany UpdateJun 20, 20248-KReg FD DisclosureJun 13, 20248-KShareholder VoteJun 7, 202410-Q10-QMay 2, 20248-KReg FD Disclosure · Company UpdateApr 25, 2024DEFA14ADEFA14AApr 22, 2024DEF 14ADEF 14AApr 22, 20248-KReg FD DisclosureMar 28, 202410-K10-KMar 7, 2024SC 13GSCHEDULE 13GFeb 13, 20248-KReg FD DisclosureFeb 13, 2024SC 13GSC 13GJan 29, 20248-KCompany UpdateJan 4, 20248-KCompany UpdateDec 21, 20238-KReg FD Disclosure · Company UpdateDec 19, 20238-KReg FD Disclosure · Company UpdateNov 28, 202310-Q10-QNov 3, 20238-KMaterial AgreementNov 1, 20238-KCompany UpdateOct 16, 2023SC 13GSC 13GOct 4, 202310-Q10-QAug 3, 20238-KShareholder VoteJul 3, 20238-KReg FD Disclosure · Company UpdateJun 29, 20238-KReg FD Disclosure · Company UpdateJun 27, 20238-KCompany UpdateJun 21, 20238-KReg FD Disclosure · Company UpdateJun 15, 2023DEF 14ADEF 14AMay 23, 202310-Q10-QMay 4, 20238-KResults of Operations · Company UpdateMay 4, 202310-K/A10-K/AApr 28, 20238-KReg FD DisclosureMar 10, 202310-K10-KMar 9, 20238-KResults of Operations · Company UpdateMar 9, 20238-KCompany UpdateMar 2, 20238-KCompany UpdateFeb 7, 20238-KMaterial Agreement · New Debt / ObligationDec 27, 20228-KCompany UpdateDec 21, 20228-KCompany UpdateDec 1, 20228-KCompany UpdateNov 29, 202210-Q10-QNov 10, 20228-KResults of Operations · Company UpdateNov 10, 20228-KReg FD Disclosure · Company UpdateOct 6, 20228-KCompany UpdateSep 14, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 19, 2026: 2 insiders bought $105K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Douglas RichardDirector | Buy | 70,000 | $1.40 | $98K |
| Mar 18, 2026 | Alfieri MichaelPrincipal Financial Officer | Buy | 5,000 | $1.42 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance